Coexpression with the inward rectifier K+ channel Kir6.1 increases the affinity of the vascular sulfonylurea receptor SUR2B for glibenclamide

Molecular Pharmacology

Volumn 56, Issue 5, 1999, Pages 955-961

  Russ, Ulrich ^a   Hambrock, Annette ^a   Artunc, Ferruh ^a   Löffler Walz, Cornelia ^a   Horio, Yoshiyuki ^b   Kurachi, Yoshihisa ^b   Quast, Ulrich ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; POTASSIUM CHANNEL; SULFONYLUREA RECEPTOR;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; RECEPTOR OCCUPANCY; VASCULAR TISSUE;

EID: 0032749713     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.56.5.955     Document Type: Article

References (39)

1. + channels. Trends Neurosci 21:288-294.
2. Ashcroft SJH and Ashcroft FM (1990) Properties and functions of ATP-sensitive K-channels. Cell Signal 2:197-214.
3. ATP channels. Annu Rev Physiol 60:667-687.
4. Bacallao R, Garfinkel A, Monke S, Zampighi G and Mandel LJ (1994) ATP depletion: A novel method to study junctional properties in epithelial tissues. I. Rearrangement of the actin cytoskeleton. J Cell Sci 107:3301-3313.
5. Beech DJ, Zhang H, Nakao K and Bolton TB (1993a) K channel activation by nudeotide diphosphates and its inhibition by glibenclamide in vascular smooth muscle cells. Br J Pharmacol 110:573-582.
6. Beech DJ, Zhang H, Nakao K and Bolton TB (1993b) Single channel and whole-cell K-currents evoked by levcromakalim in smooth muscle cells from the rabbit portal vein. Br J Pharmacol 110:583-590.
7. ATP channels. Am J Physiol 271:H2710-H2716.
8. + channel openers in rat aorta. J Biol Chem 267:11689-11692.
9. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
10. Christopoulos A (1998) Assessing the distribution of parameters in models of ligand-receptor interaction: To log or not to log. Trends Pharmacol Sci 19:351-357.
11. ATP channel subunits. Neuron 18:827-838.
12. Dorschner H, Brekardin E, Uhde I, Schwanstecher C and Schwanstecher M (1999) Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure. Mol Pharmacol 55:1060-1066.
13. Draper NB and Smith H (1981) Applied Regression Analysis, pp 85-96 and 458-517, John Wiley & Sons, Inc., New York.
14. Edwards G and Weston AH (1993) The pharmacology of ATP-sensitive potassium channels. Annu Rev Pharmacol Toxicol 33:597-637.
15. + channel to the actin cytoskeleton. Pfluegers Arch Eur J Physiol 431:504-512.
16. + channel modulator binding to sulfonylurea receptors SUR2A and SUR2B: Opposite effects of MgADP. Mol Pharmacol 55:832-840.
17. ATP channel modulator binding to the recombinant sulphonylurea receptor, SUR2B. Br J Pharmacol 125:577-583.
18. Hamill OP, Marty A, Neher E, Sakmann B and Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pfluegers Arch Eur J Physiol 391:85-100.
19. + channel. FEBS Lett 409:232-236.
20. + channel. J Biol Chem 271:24321-24324.
21. + channel in the rabbit portal vein. J Physiol (Lond) 444:397-418.
22. + channels by ATP and nucleotide diphosphate in rabbit portal vein. Am J Physiol 266:H1687-H1698.
23. Löffler C and Quast U (1997) Pharmacological characterization of the sulphonylurea receptor in rat isolated aorta. Br J Pharmacol 120:476-480.
24. 3H-glibenclamide binding in rat aortic rings. Naunyn-Schmiedebergs Arch Pharmacol 357:183-185.
25. Mauley PW, Quast U, Andres H and Bray KM (1993) Synthesis of and radioligand binding studies with a tritiated pinacidil analogue: Receptor interactions of structurally different classes of potassium channel openers and blockers. J Med Chem 36:2004-2010.
26. Quast U (1992) Potassium channel openers: Pharmacological and clinical aspects. Fundam Clin Pharmacol 6:279-293.
27. Quast U (1996) Effects of potassium channel activators in isolated blood vessels, in Potassium Channels and their Modulators: From Synthesis to Clinical Experience (Evans JM, Hamilton TC, Longman SD and Stemp G eds) pp 173-195, Taylor & Francis, London.
28. 3H]P1075 in rat isolated aorta: Relationship to functional effects of openers and blockers. Mol Pharmacol 43:474-481.
29. Quayle JM, Nelson MT and Standen NB (1997) ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol Rev 77:1165-1232.
30. Satoh E, Yamada M, Kondo C, Repunte VP, Horio Y, lijima T and Kurachi Y (1998) Intracellular nucleotide-mediated gating of SUR/Kir6.0 complex potassium channels expressed in a mammalian cell line and its modification by pinacidil. J Physiol (Lond) 511:663-674.
31. Schwanstecher M, Brandt C, Behrends S, Schaupp U and Panten U (1992) Effect of MgATP on pinacidil-induced displacement of glibenclamide from the sulphonylurea receptor in a pancreatic β-cell line and rat cerebral cortex. Br J Pharmacol 106:295-301.
32. Schwanstecher M, Löser S, Chudziak F and Panten U (1994) Identification of a 38-kDa high affinity sulfonylurea-binding peptide in insulin-secreting cells and cerebral cortex. J Biol Chem 269:17768-17771.
33. Schwanstecher M, Sieverding C, Dörschner H, Gross I, Aguilar-Bryan L, Schwanstecher C and Bryan J (1998) Potassium channel openers require ATP to bind to and act through sulfonylurea receptors. EMBO J 17:5529-5535.
34. ATP channel complex. J Gen Physiol 110:655-664.
35. Terzic A and Kurachi Y (1996) Actin microfilament disrupters enhance KATP channel opening in patches from guinea-pig cardiomyocytes. J Physiol (Lond) 492:395-404.
36. + channels in the absence of the sulphonylurea receptor. Nature (Lond) 387:179-183.
37. + current in canine coronary smooth muscle cells. Pfluegers Arch Eur J Physiol 427:110-120.
38. + channel. J Physiol (Lond) 499:715-720.
39. + channels. Pfluegers Arch Eur J Physiol 434:203-205.